Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of IV Insulin Detemir vs Human Insulin in Healthy Subjects
NCT02162407Phase 1Completed
- Sponsor
- Novo Nordisk
- Start
- Oct 1999
- Primary completion
- Dec 1999
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial of insulin detemir in diabetes mellitus (DM) (3 arms), sponsored by Novo Nordisk. Primary endpoint: Steady state glucose infusion rate (GIR) / interstitial insulin steady state concentration at 8 hours. Started Oct 1999; status: completed.
02
Drugs
insulin detemir
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT02162407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02162407.